Source: Health Canada shortage reports · Updated Jul 13, 2026
Timolol is in a widespread shortage in Canada. 6 of 12 reported products are affected. The latest manufacturer estimate for full recovery is Jul 30, 2027.
A beta blocker used mainly as eye drops to lower pressure inside the eye in glaucoma.
Products affected
6 / 12
In shortage since
Apr 15, 2016
Est. full return
Jul 30, 2027
Reports on file
61
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · since Jun 29, 2026, est. end Jul 10, 2026 · Delay in shipping of the drug.
Active shortage
APO-TIMOP
0.5% · SOLUTION · APOTEX INC
DIN 00755834 · since Jan 14, 2025, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
DIN 02242275 · since May 13, 2024, est. end Jul 30, 2027 · Disruption of the manufacture of the drug.
Active shortage
ODAN-TIMOLOL
0.5% · LIQUID · ODAN LABORATORIES LTD
DIN 02010240 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ODAN-TIMOLOL
0.25% · LIQUID · ODAN LABORATORIES LTD
DIN 02010259 · since Apr 15, 2016, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP-TIMOLOL
0.5% · SOLUTION · JAMP PHARMA CORPORATION
DIN 02447800 · ended Jun 1, 2026 · Demand increase for the drug.
Resolved
SANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TIMOLOL
0.5% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166720 · ended Dec 3, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TIMOLOL
0.25% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02166712 · ended Dec 3, 2025 · Demand increase for the drug.
Resolved
TIMOPTIC
0.5% · SOLUTION · ELVIUM LIFE SCIENCES
DIN 00451207 · ended Dec 12, 2025 · Demand increase for the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Timolol is currently affected by 6 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, APOTEX INC, ODAN LABORATORIES LTD.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Timolol is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01ED).
Recent changes
No changes recorded yet.
Common questions
What is Timolol used for?
A beta blocker used mainly as eye drops to lower pressure inside the eye in glaucoma.
When will Timolol be back in stock in Canada?
The latest manufacturer estimate is Jul 30, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Timolol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.